Chondrocyte genomics: implications for disease modification in osteoarthritis
- 30 September 2006
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 11 (17-18) , 825-832
- https://doi.org/10.1016/j.drudis.2006.07.004
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Robotic spotting of cDNA and oligonucleotide microarraysTrends in Biotechnology, 2005
- Genome-wide association studies for common diseases and complex traitsNature Reviews Genetics, 2005
- Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platformsNucleic Acids Research, 2005
- Comparison of the current RefSeq, Ensembl and EST databases for counting genes and gene discoveryFEBS Letters, 2004
- Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling ProjectBlood, 2004
- Profiling genes expressed in human fetal cartilage using 13,155 expressed sequence tagsOsteoarthritis and Cartilage, 2003
- Gene expression predictors of breast cancer outcomesThe Lancet, 2003
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- Minimum information about a microarray experiment (MIAME)—toward standards for microarray dataNature Genetics, 2001
- A map of human genome sequence variation containing 1.42 million single nucleotide polymorphismsNature, 2001